Revvity Inc.
USUSDRevvity Inc. (US:RVTY) — Biotechnology: Laboratory Analytical Instruments. Število borz, na katerih se trgujejo delnice družbe: 3. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.
O podjetju
- Spletna stran
- revvity.com
- Sektor
- Industrials · Biotechnology: Laboratory Analytical Instruments
- Sedež
- Waltham, United States
- Izvršni direktor
- Dr. Prahlad R. Singh Ph.D.
- Zaposleni
- 11 000
- Delnice v obtoku
- 111.59 mio. na dan 2026-08-06
- Prosto prenosljive delnice
- 102.49 mio.
- Tržna kapitalizacija
- 16.63 mrd. USD
- Notranje osebe
- 0.26%
- Institucionalni vlagatelji
- 96.55%
- Panoga (SIC)
- Laboratory Analytical Instruments
- LEI
- 549300IKL1SDPFI7N655
- Delež izplačila
- 13.4%
- FCF
- 558 mio. USD6%
- Dolg
- 3.21 mrd. USD3.9 let FCF
- Dividendni staž
- 43 let
- Dobički, FCF in izplačane dividende — za 12 mesecev do 05.07.2026 (najnovejše poročilo podjetja).
Opis
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Dividende
Revvity Inc. (RVTY) izplačuje dividende četrtletno. V zadnjih 12 mesecih je bilo plačanih 0.28 USD na delnico (plačila: 4). To je približno 0.18% trenutne cene delnice. Naslednji datum ex-dividende je 23.10.2026: 0.07 USD na delnico, izplačilo 13.11.2026. Leta neprekinjenih dividend: 43.
| Ex-datum | Izplačilo | Znesek | % | Vrsta | Oznaka |
|---|---|---|---|---|---|
| 2026-10-23 napovedano | 2026-11-13 | 0.0700 USD | 0.0/0.2 % | četrtletno | US:RVTY |
| 2026-07-17 | 2026-08-07 | 0.0700 USD | 0.0/0.2 % | četrtletno | US:RVTY |
| 2026-04-17 | 2026-05-08 | 0.0700 USD | 0.0/0.2 % | četrtletno | US:RVTY |
| 2026-01-16 | 2026-02-06 | 0.0700 USD | 0.0/0.2 % | četrtletno | US:RVTY |
| 2025-10-17 | 2025-11-07 | 0.0700 USD | 0.0/≈0.2 % | četrtletno | US:RVTY |
| 2025-07-18 | 2025-08-08 | 0.0700 USD | 0.0/≈0.2 % | četrtletno | US:RVTY |
| 2025-04-17 | 2025-05-09 | 0.0700 USD | 0.0/≈0.2 % | četrtletno | US:RVTY |
Novice ta teden
Sporočila za javnost s spletne strani za vlagatelje podjetja, ki se dnevno posodabljajo. Povezave vodijo na spletno stran podjetja. Naslovi so v izvirnem jeziku, kot na spletni strani podjetja.
| 06.10.2026 | Revvity to Host Investor Day |
| 02.10.2026 | Revvity to Hold Earnings Call on November 3, 2026 |
Največji imetniki
| Imetnik | Delež | Delnice | Datum poročila |
|---|---|---|---|
| T. Rowe Price Investment… | 16.37% | 18.26 mio. | 2026-06-30 |
| T. ROWE PRICE CAPITAL AP… | 10.2% | 11.38 mio. | 2026-06-30 |
| Jupiter Topco LLC | 7.74% | 8.64 mio. | 2026-06-30 |
| Edgepoint Investment Gro… | 7.66% | 8.54 mio. | 2026-06-30 |
| Blackrock Inc. | 6.86% | 7.66 mio. | 2026-06-30 |
| Vanguard Capital Managem… | 6.54% | 7.3 mio. | 2026-06-30 |
| JANUS INVESTMENT FUND-Ja… | 5.15% | 5.75 mio. | 2026-06-30 |
| Price (T.Rowe) Associate… | 4.96% | 5.53 mio. | 2026-06-30 |
| Vanguard Portfolio Manag… | 4.28% | 4.77 mio. | 2026-06-30 |
| State Street Corporation | 3.89% | 4.34 mio. | 2026-06-30 |
| Victory Capital Manageme… | 3.27% | 3.65 mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.18% | 3.55 mio. | 2026-06-30 |
| Dimensional Fund Advisor… | 3.07% | 3.43 mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.59% | 2.89 mio. | 2026-06-30 |
| -Price (T.Rowe) U.S. Val… | 2.41% | 2.69 mio. | 2026-06-30 |
| TR PRICE-Price (T.Rowe)… | 2.41% | 2.69 mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.29% | 2.56 mio. | 2026-06-30 |
| JNL Series Trust-JNL/T.… | 2.27% | 2.53 mio. | 2026-06-30 |
| Victory Portfolios-Victo… | 2.12% | 2.37 mio. | 2026-06-30 |
| T. Rowe Price Value Fund… | 1.93% | 2.16 mio. | 2026-06-30 |
| Invesco Exchange-Traded… | 1.67% | 1.87 mio. | 2026-08-31 |
| SINGH PRAHLAD R (Chief E… | ≈0.09% | 105 676 | 2026-08-13 |
| GOLDBERG JOEL S (General… | ≈0.09% | 105 223 | 2026-08-14 |
| BARRETT PETER (Director) | ≈0.03% | 28 293 | 2026-05-07 |
| WITNEY FRANKLIN R. PH.D.… | ≈0.02% | 23 354 | 2026-05-07 |
| CHAPIN SAMUEL R. (Direct… | ≈0.02% | 22 676 | 2026-05-07 |
| VICTOR MIRIAME (Officer) | ≈0.02% | 18 122 | 2026-02-24 |
| WITZ PASCALE (Director) | ≈0.01% | 15 985 | 2026-05-07 |
| KRAKOWIAK MAXWELL (Chief… | ≈0.01% | 14 781 | 2026-09-21 |
| MICHAS ALEXANDROS P (Dir… | — | — | 2026-08-25 |
| MICHAS ALEXIS P (Directo… | — | — | 2025-08-27 |
